Prijeđi na sadržaj
drdaniel.appHitna medicina & Anestezija · Notarzt Dr. Daniel Moj račun Otvori aplikaciju
App Store · Google Play

I kao aplikacija za iPhone i Android

  • AndroidGoogle Play
  • iPhoneApp Store
HR

Kraniocerebralna ozljeda

Neurologija

Za zdravstvene djelatnike. Ovi podaci ne zamjenjuju kliničku procjenu u pojedinačnom slučaju; mjerodavni su važeći sažetak opisa svojstava lijeka i navedene smjernice.

Liječnički provjereno: Dr. med. univ. Daniel Pehböck, DESA, 03.11.2026

Kraniocerebralna ozljeda: Podjela prema GCS-u, Izvanbolnički ciljevi – spriječiti sekundarno oštećenje mozga, Dišni put, ventilacija, anestezija, Prijeteće uklještenje – prepoznati i premostiti, Traneksamična kiselina, Antikoagulacija i antitrombocitni lijekovi – sažeto za timove hitne medicine, anestezije i intenzivne skrbi, s izvorima i liječnički provjereno.

Sadržaj poglavlja

  1. Podjela prema GCS-u
  2. Izvanbolnički ciljevi – spriječiti sekundarno oštećenje mozga
  3. Dišni put, ventilacija, anestezija
  4. Prijeteće uklještenje – prepoznati i premostiti
  5. Traneksamična kiselina
  6. Antikoagulacija i antitrombocitni lijekovi
  7. Epileptički napadaj
  8. Ciljna bolnica i primopredaja
  9. Laka KCO – kome treba CT?
  10. Djeca
  11. Starije i antikoagulirane osobe

U cijelosti u aplikaciji

Doze prema tjelesnoj masi u mg i ml, tablice, algoritmi i kalkulatori – i izvanmrežno, na mobitelu, tabletu i računalu. Isprobajte puni pristup besplatno 7 dana.

Lijekovi u ovom poglavlju

Izvori i smjernice

  1. Firsching R, Rickels E, Mauer UM, Sakowitz OW, Messing-Jünger M, Engelhard K et al. (DGNC, DGAI, DGN, DGNR, DGU u. a.). S2e-Leitlinie Schädel-Hirn-Trauma im Erwachsenenalter, AWMF-Register-Nr. 008-001, Update 2015 (Lang- und Kurzfassung 12/2015 bzw. 06/2016)
  2. GNPI, DGNC, DGKCH u. a. S2k-Leitlinie Das Schädel-Hirn-Trauma im Kindes- und Jugendalter, AWMF-Register-Nr. 024-018, Endfassung 14.02.2022 (Registerdokument 03/2023)
  3. Lulla A, Lumba-Brown A, Totten AM et al. Prehospital Guidelines for the Management of Traumatic Brain Injury.
  4. Brain Trauma Foundation. Guidelines for Prehospital Management of Traumatic Brain Injury, 3rd Edition (Lulla A et al.). Prehosp Emerg Care 2023;27(5):507–538; Executive Summary: Hawryluk GWJ et al. Neurosurgery 2023;93(6):E159–E169.
  5. Badjatia N, Carney N, Crocco TJ et al. Guidelines for Prehospital Management of Traumatic Brain Injury, 2nd Edition. Prehosp Emerg Care 2008;12 Suppl 1:S1–S52 (Brain Trauma Foundation): Hypoxämie < 90 % und Hypotonie < 90 mmHg systolisch vermeiden; Normoventilation (etCO₂ 35–40 mmHg); Herniationszeichen.
  6. Carney N, Totten AM, O'Reilly C et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017;80:6–15 (Brain Trauma Foundation, online 09/2016)
  7. Kochanek PM, Tasker RC, Carney N et al. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines. Pediatr Crit Care Med 2019;20(3S Suppl 1):S1–S82: Bolus hypertoner Kochsalzlösung 3 % bei intrakranieller Hypertension, wirksame Akutdosis 2–5 ml/kg über 10–20 min (Level II); Dauerinfusion 0,1–1,0 ml/kg/h; 23,4 % 0,5 ml/kg (max. 30 ml) bei refraktärem Hirndruck.
  8. Rossaint R, Afshari A, Bouillon B et al. The European guideline on management of major bleeding and coagulopathy following trauma.
  9. Ruhigstellung der Halswirbelsäule in der Präklinik. Notfall Rettungsmed 2023 (Übersicht auf Basis der S3-Leitlinie 187-023: Immobilisation beim Polytrauma indiziert; Zervikalstütze bei SHT kritisch.
  10. National Institute for Health and Care Excellence (NICE). Head injury.
  11. Stiell IG, Wells GA, Vandemheen K et al. The Canadian CT Head Rule for patients with minor head injury. Lancet 2001;357:1391–1396.
  12. Kuppermann N, Holmes JF, Dayan PS et al. (PECARN). Identification of children at very low risk of clinically-important brain injuries after head trauma.
  13. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3)
  14. Neurocritical Care Society. Emergency Neurological Life Support (ENLS)
  15. Neurocritical Care Society. ENLS Version 4.0.
  16. Bulger EM, May S, Wasserberger J et al. (ROC). Out-of-hospital hypertonic resuscitation following severe traumatic brain injury.
  17. apotheke adhoc: Hydroxyethylstärke-Lösungen gehen außer Handel.
  18. Edwards P, Arango M, Balica L et al. (CRASH trial collaborators). Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury.
  19. European Society of Anaesthesiology and Intensive Care (ESAIC). Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding. Eur J Anaesthesiol 2024;41(5):327–350.
  20. Christensen H, Cordonnier C, Kõrv J et al. European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage. Eur Stroke J 2019;4(4):294–306.
  21. Neurocritical Care Society (NCS) und Society of Critical Care Medicine (SCCM). Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update. Neurocrit Care 2026, online 24.09.2026 (aktualisiert die NCS/SCCM-Leitlinie 2016)
  22. Baharoglu MI, Cordonnier C, Al-Shahi Salman R et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH)
  23. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. Lancet 1974;2:81–4.
  24. Djakow J, Turner NM, Skellett S et al. European Resuscitation Council Guidelines 2025 Paediatric Life Support. Resuscitation 2025;215 Suppl 1:110767.
  25. AWMF-Leitlinienregister, Registernummer 008-001 Schädel-Hirn-Trauma im Erwachsenenalter: Neufassung als S2e-Leitlinie (Version 3.0) angemeldet am 31.10.2025, geplante Fertigstellung 31.12.2026, federführend Deutsche Gesellschaft für Neurochirurgie (DGNC)
  26. Neurocritical Care Society. Emergency Neurological Life Support (ENLS) Version 5.0.
  27. Sažeci opisa svojstava odobrenih pripravaka – pripravak i odjeljak za svaku dozu u aplikaciji.